Consolidated Balance Sheets - USD ($) $ in Thousands	Feb. 29, 2024	May 31, 2023
Current assets
Cash and cash equivalents	$ 78,451	$ 44,620
Accounts receivable, net of allowances of $2,560 and $2,150 respectively	49,475	52,826
Inventories	58,068	55,325
Prepaid expenses and other	10,913	4,617
Current assets held for sale	0	6,154
Total current assets	196,907	163,542
Property, plant and equipment, net	37,040	44,384
Intangible assets, net	81,570	111,144
Goodwill	0	159,238
Other assets	9,325	10,676
Non-current assets held for sale	0	43,653
Total assets	324,842	532,637
Current liabilities
Accounts payable	35,152	40,445
Accrued liabilities	30,963	26,617
Current portion of contingent consideration	9,500	14,761
Other current liabilities	10,259	2,002
Total current liabilities	85,874	83,825
Long-term debt	0	49,818
Deferred income taxes	5,917	12,813
Contingent consideration, net of current portion	0	4,535
Other long-term liabilities	14,353	3,350
Total liabilities	106,144	154,341
Commitments and contingencies (Note 14)
Stockholders' equity
Preferred stock, par value $0.01 per share, 5,000,000 shares authorized; no shares issued and outstanding	0	0
Common stock, par value $0.01 per share, 75,000,000 shares authorized; 40,794,533 and 39,981,422 shares issued and 40,424,533 and 39,611,422 shares outstanding at February 29, 2024 and May 31, 2023, respectively	385	382
Additional paid-in capital	608,588	599,206
Accumulated deficit	(381,755)	(210,855)
Treasury stock, 370,000 shares at February 29, 2024 and May 31, 2023, respectively	(5,714)	(5,714)
Accumulated other comprehensive income	(2,806)	(4,723)
Total Stockholders’ Equity	218,698	378,296
Total Liabilities and Stockholders' Equity	$ 324,842	$ 532,637